Position history for D. E. Shaw & Co., Inc.'s holdings in IMMUNITYBIO INC
D. E. Shaw & Co., Inc. holds 12.6M shares of IBRX (IMMUNITYBIO INC), worth $96.4M as of 2026-Q1. This is a new position. IBRX represents 0.1% of D. E. Shaw & Co., Inc.'s portfolio.
Current Value
$96.4M
Current Shares
12.6M
Total Value Change
+$96.4M
Total Shares Change
+12.6M
Other major holders of IBRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
New |
| 12.6M |
- |
| $96.4M |
| 0.1% |
| $10.00 |
41 |
| 2025-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $2.57 | 0 |
| 2025-Q2 | New | 237,147 | - | $626,068 | 0.0% | $2.70 | 34 |
| 2024-Q4 | Exited | 0 | -100.0% | $0 | 0.0% | $2.68 | 0 |
| 2024-Q3 | New | 520,053 | - | $1.9M | 0.0% | $3.93 | 36 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $6.32 | 0 |